Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: Ganglioside mimicry and cross-reactive antibodies

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Islam, Zhahirul ^a,b   Gilbert, Michel ^c   Mohammad, Quazi D ^d   Klaij, Kevin ^b   Li, Jianjun ^c   van Rijs, Wouter ^b   Tio Gillen, Anne P ^b   Talukder, Kaisar A ^a   Willison, Hugh J ^e   van Belkum, Alex ^b   Endtz, Hubert P ^a,b   Jacobs, Bart C ^b  

^a Emerging Diseases and Immunobiology   (Bangladesh)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^d DHAKA MEDICAL COLLEGE HOSPITAL   (Bangladesh)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; GANGLIOSIDE; GANGLIOSIDE GA2; GANGLIOSIDE GD 1A; GANGLIOSIDE GD3; GANGLIOSIDE GM1; IMMUNOGLOBULIN G; LIPOOLIGOSACCHARIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY STRUCTURE; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BANGLADESH; BLOOD SAMPLING; CAMPYLOBACTER JEJUNI; CHILD; CONTROLLED STUDY; CROSS REACTION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MOLECULAR MIMICRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PROTEIN EXPRESSION; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; BANGLADESH; CAMPYLOBACTER JEJUNI; CARBOHYDRATE SEQUENCE; CHILD; CROSS REACTIONS; FEMALE; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDES; MALE; MOLECULAR SEQUENCE DATA;

EID: 84865419938     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043976     Document Type: Article

References (37)

1. Hughes RA, Cornblath DR, (2005) Guillain-Barré syndrome. Lancet 366: 1653-1666.
2. Islam Z, Jacobs BC, Islam MB, Mohammad QD, Diorditsa S, et al. (2011) High incidence of Guillain-Barré syndromein children, Bangladesh. Emerg Infect Dis 17: 1317-1318.
3. Rees JH, Soudain SE, Gregson NA, Hughes RA, (1995) Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 333: 1374-1379.
4. Jacobs BC, Rothbarth PH, van der Meché FG, Herbrink P, Schmitz PI, et al. (1998) The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 51: 110-1115.
5. Nachamkin I, Arzarte Barbosa P, Ung H, Lobato C, Gonzalez Rivera A, et al. (2007) Patterns of Guillain-Barré syndromein children: results from a Mexican population. Neurology 69: 1665-1671.
6. Islam Z, Jacobs BC, van Belkum A, Mohammad QD, Islam MB, et al. (2010) Axonal variant of Guillain-Barré syndromeassociated with Campylobacter infection in Bangladesh. Neurology 74: 581-587.
7. Ang CW, Jacobs BC, Laman JD, (2004) The Guillain-Barré syndrome: a true case of molecular mimicry. Trends Immunol 25: 61-66.
8. Yuki N, (1997) Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome. J Infect Dis 176: S150-153.
9. Ang CW, Yuki N, Jacobs BC, Koga M, Van Doorn PA, et al. (1999) Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies. Neurology 53: 2122-2127.
10. Kusunoki S, Chiba A, Kanazawa I, (1999) Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve 22: 1071-1074.
11. Aspinall GO, Lynch CM, Pang H, Shaver RT, Moran AP, (1995) Chemical structures of the core region of Campylobacter jejuni O:3 lipopolysaccharide and an associated polysaccharide. Eur J Biochem 231: 570-578.
12. Godschalk PC, Kuijf ML, Li J, St Michael F, Ang CW, et al. (2007) Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain- Barré and Miller Fisher syndromes. Infect Immun 75: 1245-1254.
13. Asbury AK, Cornblath DR, (1990) Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27: S21-24.
14. Islam Z, van Belkum A, Cody AJ, Tabor H, Jacobs BC, et al. (2009) Campylobacter jejuni HS:23 and Guillain-Barré syndrome, Bangladesh. Emerg Infect Dis 15: 1315-1317.
15. Penner JL, Hennessy JN, Congi RV, (1983) Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens. Eur J Clin Microbiol Infect Dis 2: 378-383.
16. Jacobs BC, Hazenberg MP, van Doorn PA, Endtz HP, van der Meché FG, (1997) Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome. J Infect Dis 175: 729-733.
17. Kuijf ML, Godschalk PC, Gilbert M, Endtz HP, Tio-Gillen AP, et al. (2007) Origin of ganglioside complex antibodies in Guillain-Barré syndrome. J Neuroimmunol 188: 69-73.
18. Jacobs BC, Endtz HP, van der Meché FG, Hazenberg MP, de Klerk MA, et al. (1997) Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome. J Neuroimmunol 79: 62-68.
19. Kuijf ML, Samsom JN, van Rijs W, Bax M, Huizinga R, et al. (2010) TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation. J Immunol185: 748-755.
20. Kuijf ML, van Doorn PA, Tio-Gillen AP, Geleijns K, Ang CW, et al. (2005) Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA. J Neurol Sci 239: 37-44.
21. Li J, Koga M, Brochu D, Yuki N, Chan K, et al. (2005) Electrophoresis-assisted open-tubular liquid chromatography/mass spectrometry for the analysis of lipo-oligosaccharide expressed by Campylobacter jejuni. Electrophoresis 26: 3360-3368.
22. Yuki N, Taki T, Inagaki F, Kasama T, Takahashi M, et al. (1993) A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 178: 1771-1775.
23. Yuki N, Kuwabara S, (2007) Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology. J Peripher Nerv Syst 12: 238-249.
24. Jacobs BC, van Doorn PA, Schmitz PI, Tio-Gillen AP, Herbrink P, et al. (1996) Campylobacter jejuni infections and anti-GM1 antibodies in guillain-barré syndrome. Ann Neurol 40; 181-187.
25. Salloway S, Mermel LA, Seamans M, Aspinall GO, Nam Shin JE, et al. (1996) Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3. Infect Immun 64: 2945-2949.
26. Ang CW, Laman JD, Willison HJ, Wagner ER, Endtz HP, et al. (2002) Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. Infect Immun 70: 1202-1208.
27. Xiang SL, Zhong M, Cai FC, Deng B, Zhang XP, (2006) The sialic acid residue is a crucial component of C. jejuni lipooligosaccharide ganglioside mimicry in the induction Guillain-Barré syndrome. J Neuroimmunol 174: 126-132.
28. Kaida KD, Morita MK, Kanzaki M, Kamakura K, Motoyoshi K, et al. (2004) Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Ann Neurol 56: 567-571.
29. Kaida KI, Kanzaki M, Morita D, Kamakura K, Motoyoshi K, et al. (2006) Anti-ganglioside complex antibodies in Miller Fisher syndrome. J Neurol Neurosurg Psych 10.1136/jnnp; 087940.
30. Kaida K, Ariga T, Yu RK, (2009) Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders-a review. Glycobiology 197: 676-692.
31. Koga M, Gilbert M, Takahashi M, Li J, Koike S, et al. (2006) Comprehensive analysis of bacterial risk factors for the development of Guillain-Barré syndrome after Campylobacter jejuni enteritis. J Infect Dis 193: 547-555.
32. Nachamkin I, Liu J, Li M, Ung H, Moran AP, et al. (2002) Campylobacter jejuni from patients with Guillain- Barré syndrome preferentially expresses a GD(1a)-like epitope. Infect Immunol 70: 5299-5303.
33. Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, et al. (2002) The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem 277: 327-337.
34. Godschalk PC, Heikema Astrid P, Michel Gilbert, Tomoko Komagamine, Ang CW, et al. (2004) The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndrome; J Clin Invest. 114: 1659-1665.
35. Koga M, Takahashi M, Masuda M, Hirata K, Yuki N, (2005) Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Neurology 65: 1376-1381.
36. van Belkum A, van den Braak, Godschalk PC, Ang CW, Jacobs BC, et al. (2001) A Campylobacter jejuni gene associated with immunemediated neuropathy. Nat Med 7: 752-753.
37. Islam Z, van Belkum A, Wagenaar JA, Cody AJ, de Boer AG, et al. (2009) Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in Bangladesh. PLoS One 4: e7257.